Phase Ib/II Study of INC280 + PDR001 or PDR001 Single Agent in Advanced HCC

Clinical trial NCT02795429 · COMPLETED

Trial details

NCT number: NCT02795429
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Advanced Hepatocellular Carcinoma

Start date: 2016-06-15
Primary completion: 2021-06-01
Enrollment: 89

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.